BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SILVAPHL

All Eps Dividend Board Agm Q1 Q2 Q3

SILVAPHL 28-Jan-2021

(Q2 Un-audited): EPS was Tk. 0.20 for October-December 2020 as against Tk. 0.26 for October-December 2019; EPS was Tk. 0.54 for July-December 2020 as against Tk. 0.55 for July-December 2019. NOCFPS was Tk. 0.68 for July-December 2020 as against Tk. 0.83 for July-December 2019. NAV per share was Tk. 16.65 as on December 31, 2020 and Tk. 16.10 as on June 30, 2020.

SILVAPHL 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

SILVAPHL 20-Dec-2020

(Continuation news of SILVAPHL): to sell its entire holdings of 24,50,000 shares of Silva Pharmaceuticals Limited at prevailing market price (in the Public Market) through Stock Exchange (DSE). (end)

SILVAPHL 20-Dec-2020

Al Amin Agro Fisheries Complex Ltd., one of the Placement holders of Silva Pharmaceuticals Limited (where Mrs. Sajeda Mirza, Mr. Anwar Mirza, Mr. Abdur Rahman Shibli Mirza, and Mr. Abdur Rahman Hassan Mirza are Sponsor Directors of Al Amin Agro Fisheries Complex Ltd. and are also the Sponsors of Silva Pharmaceuticals Limited) has expressed intention (Cont.)

SILVAPHL 01-Dec-2020

Trading of the shares of the Company will resume on 02.12.2020 after record date.

SILVAPHL 30-Nov-2020

Trading of the shares of the Company will remain suspended on record date i.e., 01.12.2020.

SILVAPHL 26-Nov-2020

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 29.11.2020 to 30.11.2020. Trading of the shares of the Company will remain suspended on record date i.e., 01.12.2020.

SILVAPHL 17-Nov-2020

The auditor of the Silva Pharmaceuticals Limited has given the "Emphasis of Matter" paragraph in the Auditor's Report for the year ended on 30 June 2020. Emphasis of Matter: We draw attention to note 4.01 to the financial statements relation to "Property Plant and Equipment" which states that the company entered into material amount of cash transactions with suppliers of goods and services for the purpose of land development. Our opinion is not modified in respect of this matter.

SILVAPHL 11-Nov-2020

(Q1 Un-audited): EPS was Tk. 0.35 for July-September 2020 as against Tk. 0.29 for July-September 2019; NOCFPS was Tk. 0.42 for July-September 2020 as against Tk. 0.26 for July-September 2019. NAV per share was Tk. 16.45 as on September 30, 2020 and Tk. 16.10 as on June 30, 2020

SILVAPHL 05-Nov-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2020 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020.

Previous Next page